Certified by Founder Lodge
ErVimmune
- ND
START UP
1 Disclosed Funding Rounds $19,917,795
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Targeting shared unconventional tumor antigens in cancer immunotherapy
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 21 ,2026 | Series A | $19,917,795 |
Seventure Partners
SPRIM Global Investments
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Flashpass | $4,250,000 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)
Zell | $589,875 | (Apr 14, 2026)
Citra Space Corporation | $15,000,000 | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
